2021
DOI: 10.1016/j.arth.2021.02.040
|View full text |Cite
|
Sign up to set email alerts
|

Two-Stage Revision Total Hip Arthroplasty Without Spacer Placement: A Viable Option to Manage Infection in Patients With Severe Bone Loss or Abductor Deficiency

Abstract: Background: High rates of spacer-related complications in two-stage exchange total hip arthroplasty (THA) have been reported. Patients with advanced bone defects and abductor deficiency may benefit from a nonspacer two-stage revision. This study reports on the clinical course of a contemporary twostage exchange for periprosthetic hip infection without spacer insertion. Methods: We reviewed 141 infected THAs with extensive bone loss or abductor damage who underwent two-stage exchange without spacer placement. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 70 publications
0
10
0
1
Order By: Relevance
“…Most authors use temporary antibiotic-loaded cement spacers for the management of chronic PJI in two-stage procedures; nevertheless, there are some authors who described two-stage revision hip arthroplasty without a temporary spacer implanted in the first stage [3]. Hipfl et al [3] reported on 135 hip PJI cases: 28 patients had Paprosky femoral bone loss type ≥3A (14 patients, Paprosky type 3; 11 patients, Paprosky type 3B; and 3 patients, Paprosky type 4). The reported reinfection rate was 25% (7/28) in Paprosky femoral bone loss type ≥3A patients and 8.4% (9/107) in patients with femoral bone defect <3A according to the Paprosky classification.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Most authors use temporary antibiotic-loaded cement spacers for the management of chronic PJI in two-stage procedures; nevertheless, there are some authors who described two-stage revision hip arthroplasty without a temporary spacer implanted in the first stage [3]. Hipfl et al [3] reported on 135 hip PJI cases: 28 patients had Paprosky femoral bone loss type ≥3A (14 patients, Paprosky type 3; 11 patients, Paprosky type 3B; and 3 patients, Paprosky type 4). The reported reinfection rate was 25% (7/28) in Paprosky femoral bone loss type ≥3A patients and 8.4% (9/107) in patients with femoral bone defect <3A according to the Paprosky classification.…”
Section: Discussionmentioning
confidence: 99%
“…The reported reinfection rate was 25% (7/28) in Paprosky femoral bone loss type ≥3A patients and 8.4% (9/107) in patients with femoral bone defect <3A according to the Paprosky classification. The reason for the difference in the reinfection rates shown was insufficient debridement of the osteolytic proximal femur and retention of devitalized bone with biofilm residues [3]. The authors avoided antibiotic-laden cement spacer implantation in complex and severe proximal femur bone defect cases due to the high mechanical complication rates presented, such as dislocation, periprosthetic fractures, and spacer fractures.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The potential of biological fixation and improved implant designs have led to an increasing worldwide use of cementless components in revision THA including two-stage exchange procedures for PJI. Studies have shown promising long-term durability without compromising infection eradication rates [2,8,[23][24][25]. Besides potential of long-term stability, it is also important to consider possible failure and further need for revision.…”
Section: Introductionmentioning
confidence: 99%
“…The major concerns of this surgical strategy are compromising infection eradication without having the local antibiotic effects of the spacer and hampering reimplantation due to resulting muscle contractures ultimately leading to worse functional outcomes [ 30 ]. However, the local antimicrobial effects of the spacer do not appear to play a significant role in infection eradication [ 31 ], and comparable functional results are achievable when long interim periods are avoided [ 32 , 33 , 34 ]. To date, only a few clinical studies have been reported regarding the use of ETO in the setting of two-stage revision THA with varying surgical regimens [ 18 , 19 , 20 , 21 , 22 ] and no study has specifically investigated the safety of ETO without spacer placement.…”
Section: Introductionmentioning
confidence: 99%